Related Experiment Video
Updated: Jul 10, 2025

A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia
Published on: September 21, 2019
Severe Parainfluenza Viral Infection-A Retrospective Study of Adult Intensive Care Patients
Adam Watson1,2,3, Ryan Beecham1, Michael P W Grocott1,2,3
1General Intensive Care Unit, Southampton General Hospital, Southampton SO16 6YD, UK.
Insights
Parainfluenza virus (PIV) infection in adult intensive care units (ICUs) leads to high mortality and morbidity. This study highlights the severe outcomes for critically ill patients with PIV.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Respiratory Medicine
Background:
- Parainfluenza virus (PIV) infections are common but poorly understood in adult intensive care unit (ICU) settings.
- Limited data exists on the clinical characteristics, progression, and outcomes of PIV in critically ill adults.
Purpose of the Study:
- To describe the characteristics, clinical course, and outcomes of PIV infection in adult ICU patients.
- To identify factors associated with mortality and organ support requirements in this population.
Main Methods:
- Retrospective study of consecutive adult patients admitted to an ICU with confirmed PIV infection over a 7-year period.
- Data collected included patient demographics, laboratory results, and prognostic scores on ICU admission.
- Primary outcomes were 30-day mortality and the need for organ support.
Main Results:
- The study included 50 adult patients (mean age 67.6 years, 52% male).
- Common findings on ICU admission included a mean PaO2/FiO2 ratio of 198 mmHg and a neutrophil/lymphocyte ratio of 15.7.
- Ninety-eight percent of patients required respiratory support, and 24% needed cardiovascular support, with a 30-day mortality rate of 40%.
Conclusions:
- PIV infection in adult ICU patients is associated with substantial mortality and morbidity.
- Significant differences in clinical presentation were observed between patients with hypoxemic versus hypercapnic respiratory failure.
- Further research is needed to understand PIV pathogenesis and improve outcomes in critically ill adults.
Abstract:
There is little known about parainfluenza virus (PIV) infection in adult intensive care unit (ICU) patients. Here, we aim to describe the characteristics, clinical course and outcomes of PIV infection in adults requiring intensive care. In this retrospective study of consecutive patients admitted to our ICU with confirmed PIV infection over a 7-year period, we report the patient characteristics, laboratory tests and prognostic scores on ICU admission. The main outcomes reported are 30-day mortality and organ support required. We included 50 patients (52% male, mean age 67.6 years). The mean PaO2/FiO2 and neutrophil/lymphocyte ratios on ICU admission were 198 ± 82 mmHg and 15.7 ± 12.5. Overall, 98% of patients required respiratory support and 24% required cardiovascular support. The median length of ICU stay was 5.9 days (IQR 3.7-9.1) with a 30-day mortality of 40%. In conclusion, PIV infection in adult ICU patients is associated with significant mortality and morbidity. There were significant differences between patients who presented with primary hypoxemic respiratory failure and hypercapnic respiratory failure.
More Related Videos
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
10:47Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice
Published on: April 14, 2011
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment